Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
TUESDAY, Aug. 29, 2023 -- The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies.
The list represents the first step in a landmark program aimed...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Diabetes | Endocrinology | General Medicine | Heart | Medicare